CompletedNot applicableNCT00104663

PRION-1: Quinacrine for Human Prion Disease

Studying Acquired Creutzfeldt-Jakob disease

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Medical Research Council
Principal Investigator: John Collinge, MD, FRCP
MRC Prion Unit
Intervention: Quinacrine(drug)
Enrollment: 160 enrolled
Eligibility: 12 years · All sexes
Timeline: 2004 – 2007

Study locations (1)

National Prion Clinic, London, United Kingdom

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00104663 on ClinicalTrials.gov

← Back to all trials